J K Lau1, R W Sy2, A Corbett3, L Kritharides4. 1. Department of Cardiology, Concord Repatriation General Hospital, University of Sydney, Hospital Road Concord, Sydney, NSW 2139, Australia. Electronic address: jerrett.lau@gmail.com. 2. Department of Cardiology, Concord Repatriation General Hospital, University of Sydney, Hospital Road Concord, Sydney, NSW 2139, Australia. Electronic address: raymond.sy01@gmail.com. 3. Department of Neurology, Concord Repatriation General Hospital, University of Sydney, Hospital Road Concord, Sydney, NSW 2139, Australia. Electronic address: alastair.corbett@sydney.edu.au. 4. Department of Cardiology, Concord Repatriation General Hospital, University of Sydney, Hospital Road Concord, Sydney, NSW 2139, Australia. Electronic address: leonard.kritharides@sydney.edu.au.
Abstract
UNLABELLED: Myotonic dystrophy (MD) is a multisystem, autosomal dominant disorder best known for its skeletal muscle manifestations. Cardiac manifestations arise as a result of myocardial fatty infiltration, degeneration and fibrosis and present most commonly as arrhythmias or conduction disturbances. Guidelines regarding the optimal cardiac management of patients with MD are lacking. The present article provides a summary of the pathophysiology of cardiac problems in patients with MD and provides a practical approach to contemporary cardiac monitoring and management of these patients with a focus on the prevention of complications related to conduction disturbances and arrhythmias. METHODS: A literature search was performed using PubMed and Medline. The keywords used in the search included "myotonic dystrophy", "cardiac manifestations", "heart", "arrhythmia", "pacemaker" and "defibrillator", all terms were used in combination. In addition, "myotonic dystrophy" was searched in conjunction with "electrophysiology", "electrocardiogram", "echocardiograph", "signal averaged electrocardiograph", "magnetic resonance imaging" and "exercise stress testing". The titles of all the articles revealed by the search were screened for relevance. The abstracts of relevant titles were read and those articles which concerned the cardiac manifestations of myotonic dystrophy or the investigation and management of cardiac manifestations underwent a full manuscript review.
UNLABELLED: Myotonic dystrophy (MD) is a multisystem, autosomal dominant disorder best known for its skeletal muscle manifestations. Cardiac manifestations arise as a result of myocardial fatty infiltration, degeneration and fibrosis and present most commonly as arrhythmias or conduction disturbances. Guidelines regarding the optimal cardiac management of patients with MD are lacking. The present article provides a summary of the pathophysiology of cardiac problems in patients with MD and provides a practical approach to contemporary cardiac monitoring and management of these patients with a focus on the prevention of complications related to conduction disturbances and arrhythmias. METHODS: A literature search was performed using PubMed and Medline. The keywords used in the search included "myotonic dystrophy", "cardiac manifestations", "heart", "arrhythmia", "pacemaker" and "defibrillator", all terms were used in combination. In addition, "myotonic dystrophy" was searched in conjunction with "electrophysiology", "electrocardiogram", "echocardiograph", "signal averaged electrocardiograph", "magnetic resonance imaging" and "exercise stress testing". The titles of all the articles revealed by the search were screened for relevance. The abstracts of relevant titles were read and those articles which concerned the cardiac manifestations of myotonic dystrophy or the investigation and management of cardiac manifestations underwent a full manuscript review.
Authors: Bryan P Fitzgerald; Kelly M Conn; Joanne Smith; Andrew Walker; Amy L Parkhill; James E Hilbert; Elizabeth A Luebbe; Richard T Moxley Journal: J Neurol Date: 2016-10-12 Impact factor: 4.849
Authors: Ellis Y Kim; David Y Barefield; Andy H Vo; Anthony M Gacita; Emma J Schuster; Eugene J Wyatt; Janel L Davis; Biqin Dong; Cheng Sun; Patrick Page; Lisa Dellefave-Castillo; Alexis Demonbreun; Hao F Zhang; Elizabeth M McNally Journal: JCI Insight Date: 2019-03-21
Authors: Laia Brunet Garcia; Ankita Hajra; Ella Field; Joseph Wacher; Helen Walsh; Gabrielle Norrish; Adnan Manzur; Francesco Muntoni; Pinki Munot; Stephanie Robb; Rosaline Quinlivan; Mariacristina Scoto; Giovanni Baranello; Anna Sarkozy; Luke Starling; Juan Pablo Kaski; Elena Cervi Journal: Front Pediatr Date: 2022-06-09 Impact factor: 3.569
Authors: Alexandre Gamet; Bruno Degand; François Le Gal; Nicolas Bidegain; Anne Delaubier; Brigitte Gilbert-Dussardier; Luc Christiaens; Rodrigue Garcia Journal: Ann Noninvasive Electrocardiol Date: 2018-08-12 Impact factor: 1.468